INIS logo

INIS Radnostix, Inc.

Other OTC · Drug Manufacturers - Specialty & Generic · Healthcare

$0.07
+0.00 (+0.00%)

Radnostix, Inc. (INIS) is a company that specializes in the global manufacturing and sale of crucial nuclear medicine calibration and reference standards, cobalt-60 products, and offers contract services for producing radiopharmaceuticals and radiochemicals. Its operations are structured into five key divisions: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological Serv…

Market Cap: $37.04Mradnostix.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

80
80
Aug 13Aug 13

Quote

Day Range
$0.06 – $0.07
52-Week Range
$0.05 – $0.11
Volume
$8.5K
Market Cap
$37.04M
50-Day Avg
$0.07
200-Day Avg
$0.07
Prev Close
$0.07
Open
$0.06

Valuation & Ratios

P/E Ratio
-36.03
EPS
$-0.00
P/B Ratio
8.74
P/S Ratio
2.47
Debt/Equity
1310186.43
Current Ratio
1.16
Dividend Yield
+0.0%
Gross Margin
+24.6%

Returns & Efficiency

Return on Equity
-24.6%
Return on Assets
-5.1%
FCF Yield
+0.3%
EV/EBITDA
-18902107.07

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$13.07M$-908.0K$-0.00
2024$13.90M$8.6K$0.00
2023$12.27M$-869.0K$-0.00
2022$11.18M$-310.7K$-0.00
2021$9.66M$-2.38M$-0.01

Social Signal Score

30
5d
30
1 mentions
30d
30
1 mentions
60d
30
1 mentions
90d
30
1 mentions
news: 1

Valuation

INIShas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsprnewswire.com·2d ago·Negative

    …entory, Completes Lucerno Dynamics Asset Acquisition IDAHO FALLS, Idaho, Aug. 13, 2026 /PRNewswire/ -- Radnostix, Inc. (formerly International Isotopes Inc.) (OTCQB: INIS) ("Radnostix" or the "Company"), a manufacturer of radioisotope-focused technologies for medical, industrial, and research applications, today announced its financial results for the second quarter and six months ended June 30, 2026 and the filing of its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commis…

    View source ↗